MedTrace Logo

Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic

NCT05316064 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2024-05-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of oral administration of probiotic at 9 log colony forming unit (CFU)/day to reduce vaginal abundance of HPV in women compared to placebo via the use of vaginal self-swab.

Conditions

  • Human Papilloma Virus Infection

Interventions

BIOLOGICAL

probiotic

oral administration of probiotic at 9 log CFU/day for 12 weeks to reduce vaginal abundance of HPV in women compared to placebo via the use of vaginal self-swab.

OTHER

placebo

oral administration of primarily carrier without the probiotic for 12 weeks

Sponsors & Collaborators

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • MingTze Liong, Doctor · School of Industrial Technology USM

  • Binti Sany Salina, Doctor · Institut Perubatan & Pergigian Termaju USM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
26 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-27
Primary Completion
2023-11-28
Completion
2023-11-28

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316064 on ClinicalTrials.gov